Pharma Journalist -

Nuance Pharma announces the Center for Drug Evaluation has approved its Investigational New Drug application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine…
Read More...

Telix Pharmaceuticals Limited announces that it has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a…
Read More...

RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. announced that they have entered into definitive settlement agreements to resolve their pending litigation.  As part of the…
Read More...

Royalty Pharma plc and Arrowhead announced that Royalty Pharma has acquired a royalty interest in Amgen’s olpasiran from Arrowhead Pharmaceuticals (Nasdaq: ARWR) for $250 million in…
Read More...

After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn Beta, the vaccine was approved by the European…
Read More...

Oncopeptides AB (publ) announces that Pepaxti (melphalan flufenamide, also called melflufen) has been granted marketing authorization in combination with dexamethasone, by the Medicines…
Read More...

BioNTech SE announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing Pte.…
Read More...

Bayer announced the acquisition of German biotech start-up Targenomix. The spin-off of the Max Planck Institute for Molecular Plant Physiology (MPI MPP) uses novel systems biology and…
Read More...

Pfizer Inc. and BioNTech SE announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY Original/Omicron BA.4/BA.5 5/5 µg) has been recommended for…
Read More...

Sobi announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret (anakinra) for the treatment of coronavirus disease 2019…
Read More...